Howden C - Search Results

1

Re-evaluating the Proposed Association Between Vonoprazan and Gastric Cancer Following Eradication of H. pylori Infection.

Howden CW, Chey WD, Shah SC. Howden CW, et al. Clin Gastroenterol Hepatol. 2024 May 8:S1542-3565(24)00411-7. doi: 10.1016/j.cgh.2024.04.015. Online ahead of print. Clin Gastroenterol Hepatol. 2024. PMID: 38729385 No abstract available.

2

A Message from the Editors.

Howden CW, Loomba R. Howden CW, et al. Aliment Pharmacol Ther. 2024 Jan;59(1):4-5. doi: 10.1111/apt.17797. Aliment Pharmacol Ther. 2024. PMID: 38085944 No abstract available.

3

Editorial: PPIs and gastric cancer-Are we dealing with a carcinogen?

Malfertheiner P, Schulz C, Howden CW. Malfertheiner P, et al. Among authors: howden cw. Aliment Pharmacol Ther. 2023 Nov;58(10):1099-1100. doi: 10.1111/apt.17691. Aliment Pharmacol Ther. 2023. PMID: 37885170 No abstract available.

4

Real-world outcomes associated with vonoprazan-based versus proton pump inhibitor-based therapy for Helicobacter pylori infection in Japan.

Howden CW, Cook EE, Swallow E, Yang K, Guo H, Pelletier C, Jacob R, Sugano K. Howden CW, et al. Therap Adv Gastroenterol. 2023 May 2;16:17562848231168714. doi: 10.1177/17562848231168714. eCollection 2023. Therap Adv Gastroenterol. 2023. PMID: 37153499 Free PMC article.

5

Physiologically-based pharmacokinetic modelling to predict intragastric rifabutin concentrations in the treatment of Helicobacter pylori infection.

Howden CW, Shah S, Pendse SN, Offman E, Almenoff JS, Sheldon KL. Howden CW, et al. Aliment Pharmacol Ther. 2023 Jul;58(2):159-167. doi: 10.1111/apt.17526. Epub 2023 Apr 20. Aliment Pharmacol Ther. 2023. PMID: 37081832

6

A translational pharmacokinetic/pharmacodynamic approach supports optimal vonoprazan dosing for erosive oesophagitis and Helicobacter pylori infection.

Scarpignato C, Howden CW, Leifke E, Mulford DJ, Lahu G, Facius A, Hunt R. Scarpignato C, et al. Among authors: howden cw. Aliment Pharmacol Ther. 2023 Jul;58(1):16-25. doi: 10.1111/apt.17510. Epub 2023 Apr 17. Aliment Pharmacol Ther. 2023. PMID: 37066678

7

Relative Cost-effectiveness of Management Strategies for Uninvestigated Dyspepsia.

Ford AC, Howden CW. Ford AC, et al. Among authors: howden cw. Clin Gastroenterol Hepatol. 2023 Oct;21(11):2986-2987. doi: 10.1016/j.cgh.2023.02.001. Epub 2023 Feb 17. Clin Gastroenterol Hepatol. 2023. PMID: 36806626 No abstract available.

8

Reply.

Chey WD, Howden CW. Chey WD, et al. Among authors: howden cw. Gastroenterology. 2023 Apr;164(4):699-700. doi: 10.1053/j.gastro.2022.11.011. Epub 2022 Nov 13. Gastroenterology. 2023. PMID: 36379243 No abstract available.

9

Response to Graham.

Laine L, Sharma P, Mulford DJ, Hunt B, Leifke E, Smith N, Howden CW. Laine L, et al. Among authors: howden cw. Am J Gastroenterol. 2022 Nov 1;117(11):1882-1883. doi: 10.14309/ajg.0000000000002009. Am J Gastroenterol. 2022. PMID: 36327440 No abstract available.

10

Second exam of right colon improves adenoma detection rate: Systematic review and meta-analysis of randomized controlled trials.

Kamal F, Khan MA, Lee-Smith W, Sharma S, Acharya A, Imam Z, Farooq U, Hanson J, Pulous V, Aziz M, Chandan S, Kouanda A, Dai SC, Munroe CA, Howden CW. Kamal F, et al. Among authors: howden cw. Endosc Int Open. 2022 Oct 17;10(10):E1391-E1398. doi: 10.1055/a-1896-4499. eCollection 2022 Oct. Endosc Int Open. 2022. PMID: 36262512 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

327 results

Search Page